Irene Griswold-Prenner, CEO/CSO of Nitrome Biosciences, was previously a Co-founder and the CSO of Imago Pharmaceuticals; Senior Director of Neurobiology at iPierian and True North, and a Senior Scientist at Elan. She received her BA from Colorado University in Molecular, Cellular and Developmental Biology and PhD from University of Chicago in Physiology and Cellular Pharmacology.
This event has passed.